About Onkolyze
Onkolyze is a company based in Singapore founded in 2018 by Vivek Sheraton Muniraj and Rory Wilding. Onkolyze operates in a competitive market with competitors including Avenda Health, Onc.ai, Panakeia, Boston Medical Sciences and Nevia Bio, among others.
- Headquarter Singapore
- Founders Vivek Sheraton Muniraj, Rory Wilding
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Onkolyze Pte Ltd
-
Annual Revenue
$72.98 K (USD)358as on Apr 30, 2021
-
Net Profit
$20.44 K (USD)283as on Apr 30, 2021
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Onkolyze
Detailed funding history for Onkolyze
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Onkolyze
Investment portfolio details for Onkolyze
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Onkolyze
Detailed financials for Onkolyze
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onkolyze Comparisons
Peer comparison for Onkolyze
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Onkolyze
Onkolyze operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avenda Health, Onc.ai, Panakeia, Boston Medical Sciences and Nevia Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a focal therapy system to treat prostate cancer
|
|
| Locked | Locked | Locked |
AI platform aids cancer diagnosis and treatment for healthcare providers.
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
AI-powered colorectal cancer screening system
|
|
| Locked | Locked | Locked |
Machine learning-enabled platform for early detection of women-related diseases
|
|
| Locked | Locked | Locked |
Provider of platform for the detection of cancer
|
Detailed competitors of Onkolyze
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onkolyze
Complete news archive for Onkolyze
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Onkolyze
Onkolyze was founded in 2018.
Onkolyze is headquartered in Singapore.
Rory Wilding is the current CEO of Onkolyze. They have also founded this company.
Annual revenue of Onkolyze is $72.98K as on Apr 30, 2021.
Onkolyze was founded in 2018 in Singapore within the health technology sector. An AI-based platform is offered for cancer detection, where ultrasound images are automatically processed to segment regions of interest. Pre-populated reports adhering to the BI-RADS lexicon standard are generated from the analyzed data, supporting clinical workflows in oncology diagnostics.
Onkolyze's top competitors include Onc.ai, Avenda Health and Panakeia.